Search research articles
Contact Us
Filters
Showing results (231-240 of 256) with videos related to
Page
of 26
Sort By:
Journal of Cancer
|
May 29, 2018
Tumor PD-L1 Expression and Clinical Outcomes in Advanced-stage Non-Small Cell Lung Cancer Patients Treated with Nivolumab or Pembrolizumab: Real-World Data in Taiwan
Shu-Yung Lin, Ching-Yao Yang, Bin-Chi Liao, et al.
Plos One
|
September 13, 2014
Impact of EGFR mutation detection methods on the efficacy of erlotinib in patients with advanced EGFR-wild type lung adenocarcinoma
Jeng-Sen Tseng, Chih-Liang Wang, Ming-Shyan Huang, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 19, 2014
Shisa3 is associated with prolonged survival through promoting β-catenin degradation in lung cancer
Chun-Chieh Chen, Hsuan-Yu Chen, Kang-Yi Su, et al.
Clinical Epigenetics
|
October 4, 2024
Epigenomic biomarkers insights in PBMCs for prognostic assessment of ECMO-treated cardiogenic shock patients
Yi-Jing Hsiao, Su-Chien Chiang, Chih-Hsien Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 9, 2017
FAM198B Is Associated with Prolonged Survival and Inhibits Metastasis in Lung Adenocarcinoma via Blockage of ERK-Mediated MMP-1 Expression
Chia-Ying Hsu, Gee-Chen Chang, Yi-Ju Chen, et al.
Aging
|
June 20, 2021
Comprehensive signature analysis of drug metabolism differences in the White, Black and Asian prostate cancer patients
Yang Liu, Jia-Wei Zhou, Cun-Dong Liu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 25, 2019
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
Ching-Yao Yang, Wei-Yu Liao, Chao-Chi Ho, et al.
The Oncologist
|
May 10, 2020
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
Ching-Yao Yang, Wei-Yu Liao, Chao-Chi Ho, et al.
Cell Research
|
February 22, 2012
RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings
Shancheng Ren, Zhiyu Peng, Jian-Hua Mao, et al.
Research (Washington, D.C.)
|
August 7, 2024
Development and External Validation of an Artificial Intelligence-Based Method for Scalable Chest Radiograph Diagnosis: A Multi-Country Cross-Sectional Study
Zeye Liu, Jing Xu, Chengliang Yin, et al.
Page
of 26
Search research articles
Search
Showing results (231-240 of 256) with videos related to
Sort By:
Page
of 26
Journal of Cancer
|
May 29, 2018
Tumor PD-L1 Expression and Clinical Outcomes in Advanced-stage Non-Small Cell Lung Cancer Patients Treated with Nivolumab or Pembrolizumab: Real-World Data in Taiwan
Shu-Yung Lin, Ching-Yao Yang, Bin-Chi Liao, et al.
Plos One
|
September 13, 2014
Impact of EGFR mutation detection methods on the efficacy of erlotinib in patients with advanced EGFR-wild type lung adenocarcinoma
Jeng-Sen Tseng, Chih-Liang Wang, Ming-Shyan Huang, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 19, 2014
Shisa3 is associated with prolonged survival through promoting β-catenin degradation in lung cancer
Chun-Chieh Chen, Hsuan-Yu Chen, Kang-Yi Su, et al.
Clinical Epigenetics
|
October 4, 2024
Epigenomic biomarkers insights in PBMCs for prognostic assessment of ECMO-treated cardiogenic shock patients
Yi-Jing Hsiao, Su-Chien Chiang, Chih-Hsien Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 9, 2017
FAM198B Is Associated with Prolonged Survival and Inhibits Metastasis in Lung Adenocarcinoma via Blockage of ERK-Mediated MMP-1 Expression
Chia-Ying Hsu, Gee-Chen Chang, Yi-Ju Chen, et al.
Aging
|
June 20, 2021
Comprehensive signature analysis of drug metabolism differences in the White, Black and Asian prostate cancer patients
Yang Liu, Jia-Wei Zhou, Cun-Dong Liu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 25, 2019
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
Ching-Yao Yang, Wei-Yu Liao, Chao-Chi Ho, et al.
The Oncologist
|
May 10, 2020
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
Ching-Yao Yang, Wei-Yu Liao, Chao-Chi Ho, et al.
Cell Research
|
February 22, 2012
RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings
Shancheng Ren, Zhiyu Peng, Jian-Hua Mao, et al.
Research (Washington, D.C.)
|
August 7, 2024
Development and External Validation of an Artificial Intelligence-Based Method for Scalable Chest Radiograph Diagnosis: A Multi-Country Cross-Sectional Study
Zeye Liu, Jing Xu, Chengliang Yin, et al.
Page
of 26